Skip to content

Medical Topic

Rheumatic Diseases and Bioresonance: Clinical and Biological Findings

Small controlled human studies of bioresonance in rheumatic diseases, the antioxidant system in rheumatoid arthritis, and limits of clinical use.

Written by: Dr. Kerem Çağlayan Medically reviewed by: Dr. Kerem Çağlayan First published: September 11, 2026 Last updated: September 29, 2026 Last medical review: September 11, 2026

Preliminary evidence

Rheumatic Diseases and Bioresonance: Clinical and Biological Findings
Short answerHuman data regarding bioresonance in rheumatic diseases are scarce, but not entirely absent. In a partially placebo-controlled study from 2007 in 15-21 participants with rheumatic disease, changes favoring the active intervention were reported in certain electroacupuncture measurements, perceived health status, and specific blood parameters. In older biological studies conducted in patients with rheumatoid arthritis, mechanistic markers such as the lymphocyte antioxidant system and heat shock proteins were examined. These data constitute a clinical research signal; they are not an alternative to disease-modifying rheumatologic treatments.

Which rheumatic diseases are involved?

Rheumatic diseases are not a single diagnosis. They are a broad group encompassing rheumatoid arthritis, spondyloarthritides, connective tissue diseases, osteoarthritis, crystal arthritides, and various musculoskeletal pain conditions. For this reason, it is not accurate to generalize the results of studies on bioresonance to all rheumatologic diseases.

2007 partially placebo-controlled study

In the study published by Schuller and Galle, an exogenous MORA bioresonance approach was investigated in a small group of patients with rheumatic diseases. Depending on the parameter, 15-21 individuals were evaluated; the primary controlled endpoint was electroacupuncture measurement, while the other endpoints were perceived health status and certain biochemical blood parameters. Following active application, a significant change in the primary measurement and improvements in perceived health status and some blood indicators were reported.

Mechanistic studies in rheumatoid arthritis

In a 2002 study conducted in patients with rheumatoid arthritis, antioxidant system markers such as superoxide dismutase, catalase, glutathione peroxidase, and non-protein thiol groups were examined. The researchers reported changes toward normalization in certain enzyme activities and glutathione-related parameters after bioresonance. In another, older study, the relationship between rheumatoid arthritis and heat shock proteins was investigated in the context of bioresonance.

How do we interpret these data?

Studies are small, old, and have limited protocol standardization. Conversely, the presence of human data that are not merely anecdotal but include controlled and biological measurements is valuable from a research perspective. The most appropriate approach is to evaluate bioresonance not as a replacement for disease-modifying treatment in inflammatory rheumatologic disease, but as an additional method being investigated for pain, stress, sleep, quality of life, or complementary regulation goals.

Primary treatment in rheumatoid arthritis

In rheumatoid arthritis and other inflammatory arthritides, early diagnosis, measurement of disease activity, and, when necessary, DMARD/biologic therapies are of fundamental importance in preventing joint damage. A rheumatology evaluation should not be delayed in the presence of a new swollen joint, morning stiffness, marked inflammation, fever, or rapid loss of function.

Our approach in our Bodrum clinic

In rheumatic complaints, we first differentiate between inflammatory disease and mechanical or degenerative pain. If bioresonance is preferred, it is planned complementarily with goals for pain, sleep, fatigue, and quality of life; disease activity is monitored when necessary through CRP/ESR, physical examination, imaging, and rheumatology follow-up.

Bioresonance →   |   Pain Treatment →

References

  1. Schuller J, Galle M. Forsch Komplementmed. 2007;14(5):289-296. PMID: 17971670. PubMed
  2. Islamov BI, et al. Bull Exp Biol Med. 2002;134(3):248-250. PMID: 12511993. PubMed
  3. Islamov BI, et al. Bioresonance therapy in rheumatoid arthritis and heat shock proteins. PMID: 10640238. PubMed

Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: September 11, 2026

Medical editorial information

This content has been medically reviewed and approved by Dr. Kerem Çağlayan. It is intended for general education and does not replace an individual diagnosis or treatment plan.

Related content

Bioresonance Human Studies: Evidence Map and Research Guide

Medical Topic

Bioresonance Human Studies: Evidence Map and Research Guide

A structured evidence map of human studies of bioresonance in smoking cessation, depression, diabetes, pain, gastrointestinal complaints, thyroid, athlete recovery, allergy, and other fields.
Bioresonance Allergy Test and Food Intolerance: What Does It Measure, What Does It Not Measure?

Medical Topic

Bioresonance Allergy Test and Food Intolerance: What Does It Measure, What Does It Not Measure?

The diagnostic accuracy of bioresonance and electrodermal allergy tests, food intolerance claims, hair samples, and their differences from standard allergy tests.
Biophotons and Ultra-Weak Photon Emission: Does the Human Body Really Emit Light?

Medical Topic

Biophotons and Ultra-Weak Photon Emission: Does the Human Body Really Emit Light?

It has been scientifically demonstrated that human cells produce ultra-weak photon emission. How should the relationship of this phenomenon to metabolism, oxidative processes, and bioresonance be interpreted?